Regulation of phospholipase C in cardiac hypertrophy
The cardiomyocyte hypertrophic response to norepinephrine is considered to be mediated by PLC. However, there is very little information on the regulation of specific PLC isozyme gene and protein expression as well as activities in normal and hypertrophied myocardium. In this article, we provide an...
Saved in:
Published in | Clinical Lipidology Vol. 4; no. 1; pp. 79 - 90 |
---|---|
Main Authors | , |
Format | Journal Article Book Review |
Language | English |
Published |
London
Future Medicine Ltd
01.02.2009
Taylor & Francis Taylor & Francis Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The cardiomyocyte hypertrophic response to norepinephrine is considered to be mediated by PLC. However, there is very little information on the regulation of specific PLC isozyme gene and protein expression as well as activities in normal and hypertrophied myocardium. In this article, we provide an overview of the role of PLC-mediated signal transduction pathways in cardiac hypertrophy as well as identify some of the mechanisms that might be involved in the regulation of PLC isozyme gene expression, protein abundance and activities. From the evidence provided it is proposed that specific PLC isozymes may be involved in the cardiomyocyte hypertrophic response, and that modification of the transcriptional regulation of PLC isozymes might also prevent the progression of cardiac hypertrophy. |
---|---|
ISSN: | 1758-4299 1758-4302 2641-5321 |
DOI: | 10.2217/17584299.4.1.79 |